Delayed
BME
12:35:12 2024-03-28 pm EDT
5-day change
1st Jan Change
2.49
EUR
+0.40%
-1.19%
+10.67%
Sales 2024 *
342M
368M
Sales 2025 *
368M
396M
Capitalization
196M
211M
Net income 2024 *
14M
15.08M
Net income 2025 *
24M
25.86M
EV / Sales 2024 *
0.7
x
Net Debt
2024
*
43M
46.33M
Net Debt
2025
*
20M
21.55M
EV / Sales 2025 *
0.59
x P/E ratio 2024 *
13.1
x
P/E ratio 2025 *
7.78
x
Employees
1,331
Yield 2024 *
-
Yield 2025 *
-
Free-Float
19.99%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024
Mar. 13
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 29
CI
Spain’s Reig Jofre Names New CFO
Dec. 20
MT
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-14
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
23-07-28
CI
Transcript : Laboratorio Reig Jofre, S.A., Q4 2022 Earnings Call, Mar 07, 2023
23-03-07
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
23-02-28
CI
Why Europe's drug shortages may get worse
23-02-08
RE
Reig Jofre JV Inks Deal with Indian Pharmaceutical to Commercialize Biosimilar Medicine
22-11-02
MT
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-14
CI
Laboratorio Reig Jofre, S.A.(BME:RJF) dropped from S&P Global BMI Index
22-09-19
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
22-07-29
CI
Laboratorio Reig Jofre, S.A.s Equity Buyback announced on July 18, 2019 has Expired. The company has repurchased 74,107 shares, representing 0.1% for 0.26 million.
22-04-23
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
22-02-28
CI
Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021
21-10-29
CI
More news
1 day +0.40%
1 week -1.19%
Current month -1.19%
1 month +0.40%
3 months +11.16%
6 months +0.40%
Current year +10.67%
More quotes
Managers
Title Age Since
Chief Executive Officer
56
05-12-31
Chief Tech/Sci/R&D Officer
-
02-12-31
Chief Operating Officer
52
02-12-31
Members of the board
Title Age Since
Chief Executive Officer
56
05-12-31
Director/Board Member
-
14-12-30
Director/Board Member
-
14-12-30
More insiders
Date
Price
Change
Volume
24-03-28
2.49
+0.40%
3,394
24-03-27
2.48
-0.80%
7,817
24-03-26
2.5
+0.40%
6,955
24-03-25
2.49
+1.22%
9,853
24-03-22
2.46
-2.38%
13,352
Delayed Quote
BME, March 28, 2024 at 12:35 pm EDT
More quotes
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company's activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
More about the company
1st Jan change
Capi.
+10.67% 212M +33.46% 701B +26.24% 570B +0.93% 381B +21.03% 334B +17.51% 322B +0.74% 209B +2.95% 212B -6.05% 205B -3.61% 157B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1